Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray ValidationJohan Botling, Patrick Micke, André König et al.|Clinical Cancer Research|2012Cited by 382
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerJohanna Sofia Margareta Mattsson, Maria A. Svensson, Hans Brunnström et al.|BMC Cancer|2016Cited by 36
Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expressionJohanna Sofia Margareta Mattsson, Miklós Gulyás, Bengt Bergman et al.|Cancer Letters|2014Cited by 29
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancerAlvida Qvick, Gisela Helenius, Bianca Stenmark et al.|Molecular Medicine|2021Cited by 28
Oestrogen receptor β in NSCLC – prevalence, proliferative influence, prognostic impact and smokingChristina Karlsson, Mats G. Karlsson, Gisela Helenius et al.|Apmis|2011Cited by 19